Using Complier Average Causal Effect Estimation to Determine the Impacts of the Good Behavior Game Preventive Intervention on Teacher Implementers

2016 ◽  
Vol 44 (4) ◽  
pp. 558-571 ◽  
Author(s):  
Juliette K. Berg ◽  
Catherine P. Bradshaw ◽  
Booil Jo ◽  
Nicholas S. Ialongo
Keyword(s):  
Preventive Intervention ◽  
Causal Effect ◽  
Good Behavior Game ◽  
Average Causal Effect ◽  
Effect Estimation ◽  
Complier Average Causal Effect

Paracetamol bei Rückenschmerzen nicht empfohlen

2020 ◽  
Vol 24 (02) ◽  
pp. 54-55
Author(s):  
Arne Vielitz
Keyword(s):  
Randomized Controlled Trial ◽  
Low Back Pain ◽  
Causal Effect ◽  
Controlled Trial ◽  
Low Back ◽  
Effect Analysis ◽  
Acute Low Back Pain ◽  
Randomized Controlled ◽  
Average Causal Effect ◽  
Complier Average Causal Effect

Schreijenberg M, Lin CC, McLachlan AJ et al. Paracetamol is Ineffective for Acute Low Back Pain even for Patients Who Comply with Treatment: Complier Average Causal Effect Analysis of a Randomized Controlled Trial. Pain 2019; 160: 2848–2854. doi: 10.1097/j.pain.0000000000001685

Azithromycin distribution and childhood mortality in compliance-related subgroups in Niger: complier average causal effect and spillovers in a cluster-randomized, placebo-controlled trial

2021 ◽  
Author(s):  
Kieran S O’Brien ◽  
Ahmed M Arzika ◽  
Ramatou Maliki ◽  
Abdou Amza ◽  
Farouk Manzo ◽  
...  
Keyword(s):  
Incidence Rate ◽  
Rate Ratio ◽  
Incidence Rate Ratio ◽  
Causal Effect ◽  
Controlled Trial ◽  
Effect Analysis ◽  
Intention To Treat ◽  
Average Causal Effect ◽  
Cluster Randomized ◽  
Complier Average Causal Effect

Abstract Background Biannual azithromycin distribution to children 1–59 months old reduced all-cause mortality by 18% [incidence rate ratio (IRR) 0.82, 95% confidence interval (CI): 0.74, 0.90] in an intention-to-treat analysis of a randomized controlled trial in Niger. Estimation of the effect in compliance-related subgroups can support decision making around implementation of this intervention in programmatic settings. Methods The cluster-randomized, placebo-controlled design of the original trial enabled unbiased estimation of the effect of azithromycin on mortality rates in two subgroups: (i) treated children (complier average causal effect analysis); and (ii) untreated children (spillover effect analysis), using negative binomial regression. Results In Niger, 594 eligible communities were randomized to biannual azithromycin or placebo distribution and were followed from December 2014 to August 2017, with a mean treatment coverage of 90% [standard deviation (SD) 10%] in both arms. Subgroup analyses included 2581 deaths among treated children and 245 deaths among untreated children. Among treated children, the incidence rate ratio comparing mortality in azithromycin communities to placebo communities was 0.80 (95% CI: 0.72, 0.88), with mortality rates (deaths per 1000 person-years at risk) of 16.6 in azithromycin communities and 20.9 in placebo communities. Among untreated children, the incidence rate ratio was 0.91 (95% CI: 0.69, 1.21), with rates of 33.6 in azithromycin communities and 34.4 in placebo communities. Conclusions As expected, this analysis suggested similar efficacy among treated children compared with the intention-to-treat analysis. Though the results were consistent with a small spillover benefit to untreated children, this trial was underpowered to detect spillovers.

Sign in / Sign up

Export Citation Format

Share Document